We will talk about BIOVIA’s Generative Therapeutics Design (GTD) and integration of NVIDIA’s MolMIM generative AI to accelerate small molecule drug discovery.
Join us for a 2 hours webinar with Q&A on BIOVIA’s Generative Therapeutics Design (GTD), featuring the integration of NVIDIA’s MolMIM generative AI to accelerate small-molecule drug discovery. Learn how to explore chemical space, perform AI-driven virtual screening, and optimize candidates using structure-based modeling.
Discover how GTD enables multi-parameter optimization across key factors such as docking, pharmacophore features, ADME, pharmacokinetics, pharmacodynamics, and bioavailability—helping you design better drug candidates, faster.
